Abstract:Background: The COVID-19 pandemic has profoundly affected out-of-hospital cardiac arrest (OHCA) and disrupted the chain of survival. Even after the end of the pandemic, the risk of new variants and surges persists. Analyzing the characteristics of OHCA during the pandemic is important to prepare for the next pandemic and to avoid repeated negative outcomes. However, previous studies have yielded somewhat varied results, depending on the health care system or the specific characteristics of social structures. Objective: We aimed to investigate and compare the incidence, outcomes, and characteristics of OHCA during the prepandemic and pandemic periods using data from a nationwide multicenter OHCA registry. Methods: We conducted a multicenter, retrospective, observational study using data from the Korean Cardiac Arrest Resuscitation Consortium (KoCARC) registry. This study included adult patients with OHCA in South Korea across 3 distinct 1-year periods: the prepandemic period (from January to December 2019), early phase pandemic period (from July 2020 to June 2021), and late phase pandemic period (from July 2021 to June 2022). We extracted and contrasted the characteristics of patients with OHCA, prehospital time factors, and outcomes for the patients across these 3 periods. The primary outcomes were survival to hospital admission and survival to hospital discharge. The secondary outcome was good neurological outcome. Results: From the 3 designated periods, a total of 9031 adult patients with OHCA were eligible for analysis (prepandemic: n=2728; early pandemic: n=2954; and late pandemic: n=3349). Witnessed arrest ( P <.001) and arrest at home or residence ( P =.001) were significantly more frequent during the pandemic period than during the prepandemic period, and automated external defibrillator use by bystanders was lower in the early phase of the pandemic than during other periods. As the pandemic advanced, the rates of the first monitored shockable rhythm ( P =.10) and prehospital endotracheal intubation ( P <.001) decreased significantly. Time from cardiac arrest cognition to emergency department arrival increased sequentially (prepandemic: 33 min; early pandemic: 35 min; and late pandemic: 36 min; P <.001). Both survival and neurological outcomes worsened as the pandemic progressed, with survival to discharge showing the largest statistical difference (prepandemic: 385/2728, 14.1%; early pandemic: 355/2954, 12%; and late pandemic: 392/3349, 11.7%; P =.01). Additionally, none of the outcomes differed significantly between the early and late phase pandemic periods (all P >.05). Conclusions: During the pandemic, especially amid community COVID-19 surges, the incidence of OHCA increased while survival rates and good neurological outcome at discharge decreased. Prehospital OHCA factors, which are directly related to OHCA prognosis, were adversely affected by the pandemic. Ongoing discussions are needed to maintain the chain of survival in the event of a new pandemic. Trial Registration: ClinicalTrials.gov NCT03222999; https://classic.clinicaltrials.gov/ct2/show/NCT03222999

Journal Pre-proof Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations in COVID-19 Pandemic, 2020

Results Of Covid-19 Pandemic On Clinical Trends In Patients Hospitalized With Acute Heart Failure Decompensation In 2017-2020, Nation-wide Study

Excess of Heart Failure-Related Deaths During the 2020 COVID-19 Pandemic in Unites States

COVID-19 and Heart Failure with Preserved and Reduced Ejection Fraction Clinical Outcomes among Hospitalized Patients in the United States

A nationwide, population‐based study on specialized care for acute heart failure throughout the COVID‐19 pandemic

Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network

Impact of heart failure on COVID-19 patients: An insight from nationwide inpatient sample

COVID-19 Infection Is Associated With Increased In-Hospital Mortality and Complications in Patients With Acute Heart Failure: Insight From National Inpatient Sample (2020)

Heart Failure As a Complication of COVID-19 Infection: Systematic Review and Meta-Analysis

Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications

Cardiovascular Complications in Patients with Heart Failure and COVID-19: CARDIO COVID 19-20 Registry

Differential Mortality Among Heart Failure Patients Across Different COVID-19 Surges in New York City

Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic – Observational cohort study using Japanese administrative data

Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study

Comorbidities and mortality risk in COVID-19 patients with congestive heart failure: A comprehensive analysis

Guideline-directed medical therapy prescribing patterns and in-hospital outcomes among heart failure patients during COVID-19

Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial

Clinical presentation of severe COVID‐19 with heart failure: A single‐center retrospective study

Impact of the COVID-19 pandemic on management and outcomes of patients with acute heart failure

Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic

The Incidence and Outcomes of Out-of-Hospital Cardiac Arrest During the COVID-19 Pandemic in South Korea: Multicenter Registry Study